NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT03009981,A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer,https://clinicaltrials.gov/study/NCT03009981,,ACTIVE_NOT_RECRUITING,"This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time â‰¤ 9 months at the time of study entry.",NO,Prostate Cancer,DRUG: Apalutamide|DRUG: LHRH Analogue|DRUG: Abiraterone Acetate|DRUG: Prednisone,"PSA progression-free survival in the intent-to-treat population, To compare PSA progression-free survival in each of the experimental arms (LHRH analogue + apalutamide; LHRH analogue + apalutamide +abiraterone acetate) versus the control arm (LHRH analogue) among all randomized patients (intent-to-treat population)., 36 months","PSA progression-free survival in the testosterone-evaluable population, Compare PSA progression-free survival in testosterone-evaluable population in each experimental arm versus the control arm. Testosterone-evaluable population includes all patients who achieve serum testosterone recovery to \> 50 ng/dL with subsequent PSA measurements sufficient for evaluation, 36 months|PSA progression-free survival in both the intent-to-treat and testosterone-evaluable populations, To compare the 36-month PSA progression-free survival rate in each experimental arm versus the control arm in both the intent-to-treat and testosterone-evaluable populations., 36 months|Serum testosterone, To compare the time to recovery of serum testosterone to greater than 50 ng/dL in each experimental arm versus the control arm., 12 months|Time to castration resistance, To compare the time to castration resistance in each experimental arm versus the control arm., 6 years|Metastasis-Free Survival, To compare metastasis-free survival in each experimental arm versus the control arm., 6 years|Overall Survival, To compare overall survival in each experimental arm versus the control arm., 6 years|Number of participants with treatment-related adverse events as assessed by CTCAE v4.0, To characterize the safety profile in each treatment arm, 6 years|Quality of life Expanded Prostate Cancer Index Composite (EPIC), Expanded Prostate Cancer Index Composite (EPIC), 72 months|Quality of life Hot Flash Daily Interference Scale (HFRDIS), Hot Flash Daily Interference Scale (HFRDIS), 72 months|Quality of life EQ-5D-5L, EQ-5D-5L, 72 months|Quality of life PROMIS Fatigue, PROMIS Fatigue, 72 months|Quality-adjusted survival, To compare the quality-adjusted survival (overall survival multiplied by utility score) of patients in each experimental arm versus the control arm., 72 months",,"Alliance Foundation Trials, LLC.","Janssen Research & Development, LLC",MALE,"ADULT, OLDER_ADULT",PHASE3,504,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,AFT-19,2017-03-06,2025-07-01,2026-01-01,2017-01-04,,2025-03-25,"The Mayo Clinic - Phoenix, Phoenix, Arizona, 85054, United States|Sharp Memorial Hospital, Chula Vista, California, 91911, United States|City of Hope National Medical Center, Duarte, California, 91010, United States|Palo Alto Medical Foundation, Fremont, California, 94538, United States|VA Central California Health Care System, Fresno, California, 93703, United States|Sharp Memorial Hospital, La Mesa, California, 91942, United States|Palo Alto Medical Foundation, Mountain View, California, 94040, United States|Palo Alto Medical Foundation, Palo Alto, California, 94301, United States|Adventist Health St. Helena/St. Helena Hospital/Martin O'Neil Cancer Center, Saint Helena, California, 94574, United States|University of California San Diego - Moores Cancer Center, San Diego, California, 92093, United States|Sharp Memorial Hospital, San Diego, California, 92123, United States|University of California San Francisco, San Francisco, California, 94158, United States|Palo Alto Medical Foundation, Santa Cruz, California, 95065, United States|Palo Alto Medical Foundation, Sunnyvale, California, 94086, United States|Georgetown University Medical Center, Washington, District of Columbia, 20007, United States|MedStar Washington Hospital Center, Washington, District of Columbia, 20007, United States|Pali Momi Medical Center, 'Aiea, Hawaii, 96701, United States|University of Hawaii Cancer Center, Honolulu, Hawaii, 96813, United States|Rush University Medical Center, Chicago, Illinois, 606012, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, 60637, United States|Northshore University Health System, Evanston, Illinois, 60201, United States|Loyola University, Maywood, Illinois, 60153, United States|Quincy Medical Group, Quincy, Illinois, 62301, United States|Carle Cancer Center, Urbana, Illinois, 61801, United States|Cancer Center of Kansas, Wichita, Kansas, 67214, United States|Eastern Maine Medical Center, Brewer, Maine, 04412, United States|New England Cancer Specialists, Kennebunk, Maine, 04043, United States|New England Cancer Specialists, Scarborough, Maine, 04074, United States|New England Cancer Specialists, Topsham, Maine, 04086, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute, Milford, Massachusetts, 01757, United States|Dana Farber Cancer Institute, South Weymouth, Massachusetts, 02190, United States|University of Minnesota, Minneapolis, Minnesota, 55455, United States|Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota, 55416, United States|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States|Nebraska Methodist Hospital, Omaha, Nebraska, 68114, United States|Nevada Cancer Research Foundation, Las Vegas, Nevada, 89106, United States|New Hampshire Oncology & Hematology, Concord, New Hampshire, 03301, United States|New Hampshire Oncology & Hematology, Hooksett, New Hampshire, 03106, United States|Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, 07920, United States|Memorial Sloan Kettering Cancer Center, Middletown, New Jersey, 07748, United States|Atlantic Health System/Morristown Medical Center, Morristown, New Jersey, 07962, United States|New Mexico Oncology Hematology Consultants, Albuquerque, New Mexico, 87109, United States|University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, 87131, United States|Memorial Medical Center- Cancer Center, Las Cruces, New Mexico, 88011, United States|Christus St. Vincent's Regional Cancer Center, Santa Fe, New Mexico, 87505, United States|VA Western New York, Buffalo, New York, 14215, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|Memorial Sloan Kettering Cancer Center, Commack, New York, 11725, United States|Memorial Sloan Kettering Cancer Center, Harrison, New York, 11533, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Weill Cornell Medical Ctr - New York Presbyterian Hospital, New York, New York, 10065, United States|Montefiore Medical Center, New York, New York, 10461, United States|SUNY Upstate Medical University, Syracuse, New York, 13210, United States|University of North Carolina Hospital, Chapel Hill, North Carolina, 27514, United States|Novant Health Presbyterian Medical Center, Charlotte, North Carolina, 28204, United States|VA Salisbury, Salisbury, North Carolina, 28144, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27157, United States|Dayton Physicians Miami Valley South, Centerville, Ohio, 45459, United States|The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States|The Toledo Clinic, Toledo, Ohio, 43623, United States|Oklahoma Cancer Specialists and Research Institute, Tulsa, Oklahoma, 74146, United States|Providence Portland Medical Center, Portland, Oregon, 97213, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15232, United States|Spartanburg Medical Center/Gibbs Cancer Center, Spartanburg, South Carolina, 29303, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Marshfield Clinic Cancer Center, Marshfield, Wisconsin, 54449, United States|Froedtert Hospital/Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States",
